Susan Hariri

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Human papillomavirus genotypes in high-grade cervical lesions in the United States
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 206:1878-86. 2012
  2. pmc HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006
    Susan Hariri
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 7:e34044. 2012
  3. doi request reprint The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Cancer Causes Control 23:281-8. 2012
  4. doi request reprint Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006
    Susan Hariri
    Division of STD Prevention, National Center for Hepatitis, HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 204:566-73. 2011
  5. ncbi request reprint Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994
    Susan Hariri
    National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Sex Transm Dis 35:298-303. 2008
  6. doi request reprint Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
    Suzanne E Powell
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, NE MS E02, Atlanta, GA 30333, USA
    Vaccine 31:109-13. 2012
  7. doi request reprint Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Lauri E Markowitz
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Infect Dis 208:385-93. 2013
  8. doi request reprint Can clinical tests help monitor human papillomavirus vaccine impact?
    Elissa Meites
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
    Int J Cancer 133:1101-6. 2013
  9. doi request reprint Post-licensure monitoring of HPV vaccine in the United States
    Lauri E Markowitz
    Centers for Disease Control and Prevention, MS E05, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Vaccine 28:4731-7. 2010
  10. doi request reprint Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008
    La shan D Taylor
    National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Rd, N E, Mailstop E 02, Atlanta, GA 30333, USA
    Prev Med 52:398-400. 2011

Collaborators

Detail Information

Publications15

  1. doi request reprint Human papillomavirus genotypes in high-grade cervical lesions in the United States
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 206:1878-86. 2012
    ..Monitoring HPV types in CIN2+ may be used to assess HPV vaccine impact...
  2. pmc HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006
    Susan Hariri
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 7:e34044. 2012
    ..This study aimed to evaluate 2 commercial assays for HPV detection and typing using FFPE cervical specimens...
  3. doi request reprint The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Cancer Causes Control 23:281-8. 2012
    ..Implementation of a feasible and sustainable surveillance system for HPV-associated cervical precancers will enable evaluation of the direct impact of HPV vaccination...
  4. doi request reprint Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006
    Susan Hariri
    Division of STD Prevention, National Center for Hepatitis, HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 204:566-73. 2011
    ..HPV vaccines prevent infection with HPV 16 and 18, which account for 70% of cases of cervical cancer, and HPV 6 and 11, which cause 90% of the cases of anogenital warts...
  5. ncbi request reprint Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994
    Susan Hariri
    National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Sex Transm Dis 35:298-303. 2008
    ..The objectives of this study were to estimate the national seroprevalence and evaluate predictors of HPV-11 seropositivity...
  6. doi request reprint Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
    Suzanne E Powell
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, NE MS E02, Atlanta, GA 30333, USA
    Vaccine 31:109-13. 2012
    ..This report describes vaccination status in women diagnosed with CIN2+ and examines HPV vaccine impact on HPV 16/18-related CIN2+...
  7. doi request reprint Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Lauri E Markowitz
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Infect Dis 208:385-93. 2013
    ..In 2010, 3-dose vaccine coverage was only 32% among 13-17 year-olds. Reduction in the prevalence of HPV types targeted by the quadrivalent vaccine (HPV-6, -11, -16, and -18) will be one of the first measures of vaccine impact...
  8. doi request reprint Can clinical tests help monitor human papillomavirus vaccine impact?
    Elissa Meites
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
    Int J Cancer 133:1101-6. 2013
    ..Further investigation is warranted to inform type-specific HPV monitoring approaches around the world. ..
  9. doi request reprint Post-licensure monitoring of HPV vaccine in the United States
    Lauri E Markowitz
    Centers for Disease Control and Prevention, MS E05, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Vaccine 28:4731-7. 2010
    ..We review systems in place or being established for post-licensure monitoring of HPV vaccine in the United States...
  10. doi request reprint Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008
    La shan D Taylor
    National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Rd, N E, Mailstop E 02, Atlanta, GA 30333, USA
    Prev Med 52:398-400. 2011
    ....
  11. doi request reprint Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries
    Charlene A Wong
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 29:878-85. 2011
    ....
  12. doi request reprint Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers
    Niti R Mehta
    Yale School of Public Health and Connecticut Emerging Infections Program, New Haven, Connecticut 06520, USA
    Obstet Gynecol 119:575-81. 2012
    ....
  13. doi request reprint Adolescent vaccination-coverage levels in the United States: 2006-2009
    Shannon Stokley
    Centers forDisease Control and Prevention, Atlanta, GA 30333, USA
    Pediatrics 128:1078-86. 2011
    ..From 2005 through 2007, 3 vaccines were added to the adolescent vaccination schedule: tetanus-diphtheria-acellular pertussis (TdaP); meningococcal conjugate (MenACWY); and human papillomavirus (HPV) for girls...
  14. pmc Epidemiology of human immunodeficiency virus in the United States
    Susan Hariri
    HIV Incidence and Case Surveillance Branch, Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention Proposed, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 20:478-88, table of contents. 2007
    ....
  15. ncbi request reprint Family history of type 2 diabetes: a population-based screening tool for prevention?
    Susan Hariri
    Epidemic Intelligence Service Officer, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Genet Med 8:102-8. 2006
    ..To evaluate the use of self-reported family medical history as a potential screening tool to identify people at-risk for diabetes...